Back to School: How biopharma can reboot drug development. Access exclusive analysis here

MA09-hRPE cells: Phase I/II ongoing

Advanced Cell Technology said an independent DSMB recommended continuation of enrollment in the third cohort in

Read the full 161 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE